2026 NPPES data Glaucoma Specialist (Ophthalmology) Physician NPI 1033130315 M.D.
Verify on CMS →

PAUL LAMA, M.D.

Glaucoma Specialist (Ophthalmology) Physician in ROCHELLE PARK, New Jersey. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
8K
Medicare Part D claims · 1K beneficiaries · Glaucoma Specialist (Ophthalmology) Physician avg: 3K
Generic prescribing
63%
generic claims · 37% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
100/100
▲ 17 pts above national avg 83.1 · [object Object]
Industry payments
$12.5K
27 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

PAUL LAMA, M.D. reported a CMS MIPS final score of 100/100 — above the 83.1 national average — and filed 8,205 Medicare Part D claims in 2023.

100/100
MIPS score · +17 vs avg
8K
Part D claims, 2023
63%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

PAUL LAMA, M.D.'s MIPS score vs every scored U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure

100 Top 7% higher than 93% of 477,587 scored providers

0–10: 8,684 scored providers (2%). Below this entry. 10–20: 3,008 scored providers (1%). Below this entry. 20–30: 3,069 scored providers (1%). Below this entry. 30–40: 2,746 scored providers (1%). Below this entry. 40–50: 2,928 scored providers (1%). Below this entry. 50–60: 5,882 scored providers (1%). Below this entry. 60–70: 13,906 scored providers (3%). Below this entry. 70–80: 118,074 scored providers (25%). Below this entry. 80–90: 129,887 scored providers (27%). Below this entry. 90–100: 189,403 scored providers (40%). This entry sits in this band. This provider 0 100 every MIPS-scored clinician, bucketed by value

Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

Board certification likely (heuristic — not verified)

PAUL LAMA, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about PAUL LAMA, M.D.?

High performer (top quartile)

NPI registry status

Active

Issued 07/21/2006

NPI 1033130315

Primary specialty

Glaucoma Specialist (Ophthalmology) Physician

Rare

354 US NPIs in this specialty

Medicare Part D claims

8,205 177% vs specialty avg

2023 prescription claims

Specialty avg: 2,962

MIPS final score

100/100 16.900000000000006% pts

Exceptional band

vs 83.1 national avg

Specialty distribution in New Jersey

How Glaucoma Specialist (Ophthalmology) Physician compares to other specialties among New Jersey providers

New Jersey providers

Glaucoma Specialist (Ophthalmology) Physician share within New Jersey

1. Glaucoma Specialist (Ophthalmology) Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Glaucoma Specialist (Ophthalmology) Physician share within New Jersey

Medicare quality performance — MIPS

PAUL LAMA, M.D.'s 2023 MIPS final score plotted against the Glaucoma Specialist (Ophthalmology) Physician national average

High performer (top quartile)
MIPS Final Score
100/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Glaucoma Specialist (Ophthalmology) Physician) — 100/100 vs national avg 83.1

0%100%National avg83%99%
MIPS final score (Glaucoma Specialist (Ophthalmology) Physician) — 100/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

PAUL LAMA, M.D. appears in the CMS NPPES registry as a Glaucoma Specialist (Ophthalmology) Physician provider holding M.D. credentials at 87 W PASSAIC ST, ROCHELLE PARK, NJ, 07662, with a listed phone of (201) 343-3499. NPI 1033130315 was issued on 07/21/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what LAMA most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 8,205 prescription claims written by this provider, covering 1,272 Medicare beneficiaries and totaling roughly $1.4 million in drug spend, split 37% brand-name and 63% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 100/100 for the 2023 performance year (Quality 100), compared with the national average of 83.1.

Glaucoma Specialist (Ophthalmology) Physician is a narrow specialty nationwide, with 354 enrolled providers across 42 states and an average of 2,962 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

87 W PASSAIC ST
ROCHELLE PARK, NJ 07662

Provider Details

NPI 1033130315
Specialty Glaucoma Specialist (Ophthalmology) Physician
Credentials M.D.
Gender Male
NPI Issued 07/21/2006

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

100
Final Score
Avg: 83.1
100
Quality

Reporting: Group practice

Hospital and facility affiliations

Facilities where PAUL LAMA, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

GLAUCOMA INSTITUTE OF NORTHERN NEW JERSEY LLC
WEST ORANGE, NJ

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for PAUL LAMA, M.D.. Source: openpaymentsdata.cms.gov.

Total received

$12.5K

Largest payer

Glaukos Corporation

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

Brand vs generic prescribing mix · Above average

PAUL LAMA, M.D. — brand share 37.0%
Specialty average (est.)

37% brand-name claims vs 63% generic, on 8,205 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

8,205
Total Claims
$1.4M
Total Drug Cost
1,272
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
17,014
Total Day Supply
498,963
Brand vs Generic
37% brand / 63% generic
Brand Drug Cost
$1.1M
Generic Drug Cost
$293K
Antibiotic Claims
20

Patient Demographics

Average Patient Age
77.9 years
Avg HCC Risk Score
1.20
Gender Split
53% female / 47% male
Age Distribution
<65: 39, 65-74: 413, 75-84: 551, 85+: 269

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What PAUL LAMA, M.D. prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Latanoprost
1,524
Dorzolamide-Timolol
Dorzolamide Hcl/Timolol Maleat
1,212
Timolol Maleate
807
Lumigan
Bimatoprost
498
Brimonidine Tartrate
493
Dorzolamide Hcl
399
Rhopressa
Netarsudil Mesylate
306
Pilocarpine Hcl
298
Alphagan P
Brimonidine Tartrate
291
Prednisolone Acetate
282

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Glaucoma Specialist (Ophthalmology) Physician Overview

How PAUL LAMA, M.D. fits within the Glaucoma Specialist (Ophthalmology) Physician landscape nationally.

354
Glaucoma Specialist (Ophthalmology) Physician Providers in US
42
States with Glaucoma Specialist (Ophthalmology) Physician
2,962
Avg Claims per Provider

PAUL LAMA, M.D.'s 8,205 claims are above the specialty average of 2,962.

Nearby Glaucoma Specialist (Ophthalmology) Physician Providers in New Jersey

Other clinicians with the same primary specialty enrolled in New Jersey, drawn from the same CMS NPPES roster as LAMA.

Compare Glaucoma Specialist (Ophthalmology) Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is PAUL LAMA, M.D.'s specialty?
PAUL LAMA, M.D. specializes in Glaucoma Specialist (Ophthalmology) Physician and practices in ROCHELLE PARK, New Jersey. Credentials: M.D..
How much does PAUL LAMA, M.D. prescribe under Medicare Part D?
In 2023, PAUL LAMA, M.D. wrote 8,205 Medicare Part D claims totaling $1.4M in drug costs for 1,272 beneficiaries.
What is PAUL LAMA, M.D.'s Medicare quality score?
PAUL LAMA, M.D. has a CMS MIPS Final Score of 100/100 (Quality: 100). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is PAUL LAMA, M.D. located?
PAUL LAMA, M.D. is located at 87 W PASSAIC ST, ROCHELLE PARK, NJ, 07662. Phone: (201) 343-3499.
What is PAUL LAMA, M.D.'s NPI number?
PAUL LAMA, M.D.'s National Provider Identifier (NPI) is 1033130315, issued on 07/21/2006.
Does PAUL LAMA, M.D. prescribe more brand-name or generic drugs?
PAUL LAMA, M.D.'s prescribing is 37% brand-name and 63% generic drugs by claim count, with $1.1M in brand drug costs.
How many Glaucoma Specialist (Ophthalmology) Physician providers are there in the US?
There are 354 Glaucoma Specialist (Ophthalmology) Physician providers across 42 states in the US. The average Glaucoma Specialist (Ophthalmology) Physician provider writes 2,962 Medicare Part D claims per year.
What drugs does PAUL LAMA, M.D. prescribe most often?
Based on 2023 Medicare Part D data, PAUL LAMA, M.D.'s most frequently prescribed drugs include Latanoprost, Dorzolamide-Timolol, Timolol Maleate. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does PAUL LAMA, M.D. accept Medicare?
PAUL LAMA, M.D. appears in CMS Medicare data with 8,205 Part D claims and 1,272 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify PAUL LAMA, M.D.'s credentials?
PAUL LAMA, M.D.'s NPI is 1033130315 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology